STOCK PURCHASE AGREEMENTStock Purchase Agreement • January 23rd, 2020 • Zanganeh Maky • Pharmaceutical preparations • New York
This Stock Purchase (this “Agreement”) is dated as of December 24, 2019, and entered into between Robert Duggan, an individual (the “Seller”) and each of the parties listed on Exhibit A hereto (each such party, a “Buyer”, and each of the Buyers and the Seller, a “Party” to this Agreement, and collectively, the “Parties”) for the purchase of certain equity interests of Summit Therapeutics plc, a public limited company incorporated in England and Wales with the Registrar of Companies of England and Wales (the “Company”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 23rd, 2020 • Zanganeh Maky • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares, par value £0.01 per share, of Summit Therapeutics PLC, a foreign private issuer incorporated in England and Wales. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
